Page 5 - Sachs Associates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sachs associates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sachs Associates Today - Breaking & Trending Today

Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum

MELBOURNE, AustraliaandSAN FRANCISCO, Jan. 3, 2023 /PRNewswire/ Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that David Stamler, M.D., Chief Executive Officer will participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum (NIF). The forum is taking place Sunday, January 8, 2022, as part of the activities surrounding the annual J.P. Morgan Healthcare Conference. At the conference, Dr. Stamler will be featured on a panel entitled, "New Approaches to Parkinson's and Movement Disorders." He will also present a company update and participate in investor and business development meetings. The program for the 6th Annual NIF is designed to cover the latest developments in global bio-partnering and investment, with additional panels covering scientific advances in key therapeutic areas ....

United States , San Francisco , David Stamler , Neuroscience Innovation Forum , Movement Disorders He , Alterity Therapeutics , Sachs Associates , Chief Executive Officer , Annual Neuroscience Innovation Forum , Movement Disorders ,

Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum

Alterity Therapeutics to Participate in the Sachs Associates 6th Annual Neuroscience Innovation Forum
kualalumpurtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kualalumpurtimes.com Daily Mail and Mail on Sunday newspapers.

United States , San Francisco , David Stamler , Neuroscience Innovation Forum , Movement Disorders He , Alterity Therapeutics , Sachs Associates , Chief Executive Officer , Annual Neuroscience Innovation Forum , Movement Disorders ,

Spexis announces presentation of half-year 2022 financial results and participation at upcoming industry and investor events in September

Spexis AG / Key word(s): Half Year Results Spexis announces presentation of half-year 2022 financial results and participation at upc. ....

United States , United Kingdom , Switzerland General , Biopharm America , Brigitte Keller Laurie Doyle , Hernan Levett , Stephan Feldhaus , Stephan Wehselau , Raimund Gabriel , Mc Services , Biotech In Europe Forum , Sachs Associates , Business Update , Investor Relations , Fall Conference , Annual Biotech ,

Humanigen Announces Participation and Presentation at Multiple Conferences in October

BURLINGAME, Calif. (BUSINESS WIRE) Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm,’ announced that management will present and participate at multiple virtual investor conferences in October. ....

Mindy Halikman Heyer , Ken Trbovich , Cameron Durrant , Christopher Hunter , Dale Chappell , International Cytokine Interferon Society , Sachs Associates , Meeting Of The International Cytokine Interferon Society , Humanigen Inc , Healthtech Investment Forum , Annual Vaccines , Infectious Diseases , Chief Scientific Officer , Investor Relations , Annual Healthtech Investment , Annual Meeting , International Cytokine , Interferon Society , Exhibitor Breaking News Session , Central European Time , Mindy Halikman Heyer Distinguished Professor , Veterinary Medicine , October Cytokines , Host Disease ,

NOXXON to Participate in Biotech and Health-Tech Conferences in October 2021

Press release content from Business Wire. The AP news staff was not involved in its creation. ....

France General , Corinne Venot , Guillaume Van Renterghem , Arthur Rouill , Aram Mangasarian , Pharmanv Euronext , Merck Keytruda , Phil Lhuillier , Khatereh Ahmadi , Oncology Bdl Panel , Biotech In Europe Forum , Merck Sharp Dohme Corp , Sachs Associates , Euronext Growth Paris , Healthtech Innovation Days , Europe Forum , Tech Innovation Days , France Biotech , Locust Walk , Phill Huillier , Merck Sharp , Media Relations , Business Wire ,